¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Maf Transcription Factors, Small"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® small intestine ÇÑ±Û ÀÛÀºÃ¢ÀÚ, ¼ÒÀå
¼³¸í   
  À§¿Í Å«Ã¢ÀÚ »çÀÌÀÇ ±æÀÌ 5m³»¿ÜÀÇ ¼ÒÈ­±â°üÀ¸·Î¼­ »ùâÀÚ, ºóâÀÚ, µ¹Ã¢ÀÚÀÇ ¼¼ ºÎºÐÀ¸·Î ±¸¼ºµÊ.
  
  1)»ùâÀÚ: ¼ÒÀåÀÇ Á¦ÀϠùºÎºÐÀ¸·Î¼­ ±æÀÌ 25cmÀÇ CÀÚÇü¸ð¾ç. »óºÎ, ³»¸², °¡·Î, ¿À¸§ÀÇ ³×ºÎÀ§·Î ±¸¼ºµÇ¸ç, »óºÎ ºÎÀ§¸¦ Á¦¿ÜÇϰí´Â ¸ðµÎ µÚº¹º®¿¡ °íÁ¤µÇ¾î ÀÖÀ¸¸ç ³»ºÎ¿¡´Â µ¹¸²ÁÖ¸§À̶ó´Â Á¡¸· ÁÖ¸§ÀÌ Á¸ÀçÇÔ. À§¿¡¼­ ³Ñ¾î¿Â ¼ÒÈ­µÈ À½½ÄÀÌ ´ãÁó, ÀÌÀھ׿¡¼­ ºÐºñµÇ´Â ¼ÒÈ­È¿¼Ò¾×)°ú ¼¯À̴ Àå¼ÒÀ̸ç Ã¶ÀÌ Èí¼öµÇ´Â Àå¼ÒÀÓ.
  
  2)ºóâÀÚ:ÀÛÀºÃ¢ÀÚÀÇ µÎ¹øÂ° ºÎºÐÀ¸·Î¼­ ±ÙÀ§ºÎ 2/5¸¦ Â÷ÁöÇÔ. °øÀåÀº È¸Àå¿¡ ºñÇØ Á÷°æÀÌ Å©°í À庮ÀÌ µÎ²¨¿ì¸ç Ç÷°üÀ̠dzºÎÇϰí Àå°£¸·ÀÌ Åõ¸íÇϰí Á÷ÇàÇ÷°üÀÌ ±ä °ÍÀ̠Ư¡ÀÓ.
  
  3)µ¹Ã¢ÀÚ:ÀÛÀºÃ¢ÀÚÀÇ ¸¶Áö¸· ºÎºÐÀ¸·Î¼­ ¿øÀ§ºÎ 3/5À» Â÷ÁöÇÔ. Æ¯È÷ µ¹Ã¢ÀÚ, Å«Ã¢ÀÚ ÀÌÇàºÎ ºÎÀ§¿¡´Â ÆÄÀ̾îÆÇÀ̶ó´Â ¸²ÇÁÀýÀÌ Á¸ÀçÇϸç, À̰÷Àº °¢Á¾ Áúº´ÀÇ Áß¿äÇÑ ¹ß»ý ºÎÀ§°¡ µÊ. ´ãÁó¿° ¹× ºñŸ¹Î B12°¡ Èí¼öµÇ´Â Àå¼ÒÀÓ.
¿µ¹® small bowel series ÇÑ±Û ÀÛÀºÃ¢ÀÚ Á¶¿µ¼ú, ¼ÒÀå Á¶¿µ¼ú
¼³¸í   
  ¹æ»ç¼± Á¶¿µÁ¦(¹æ»ç¼±°Ë»ç¿¡¼­ ´Ù¸¥ ºÎÀ§¿Í ´ëÁ¶µÇ´Â ¾ÆÁÖ Èò»öÀ» ¶ì´Â ¹°Áú)ÀΠ¹Ù·ýÀ» ¼·ÃëÇÑ µÚ, ÃÔ¿µÇϴ ÀÛÀºÃ¢ÀÚÀÇ ±âº»ÀûÀΠ¹æ»ç¼± °Ë»ç·Î¼­, ¹æ¹ýÀº 200~300mLÀÇ ¹Ù·ýÀ» ¸ÔÀºµÚ ¹Ù·ýÀÌ ÀÛÀº Ã¢ÀÚ¸¦ Åë°úÇϴ µ¿¾È Á¤±ÔÀû °£°ÝÀ¸·Î ¹æ»ç¼± »çÁøÀ» ÂïÀ½. ÀϹÝÀûÀ¸·Î 2~3½Ã°£ÀÌ °É¸².
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reverse transcription
    ¿ªÀü»ç
  • chronic lymphoblastic leukemia/small lymphocytic lymphoma
    ¸¸¼º¸²ÇÁ¸ð±¸¹éÇ÷º´/¼Ò¸²ÇÁ±¸¸²ÇÁÁ¾
  • non-small cell carcinoma
    ºñ¼Ò¼¼Æ÷¾ÏÁ¾
  • small cell carcinoma
    ¼Ò¼¼Æ÷¾ÏÁ¾
  • small cell lung cancer
    ¼Ò¼¼Æ÷Æó¾Ï, ÀÛÀº¼¼Æ÷ÇãÆÄ¾Ï
  • small for gestational age
    ÀӽųªÀ̺¸´Ù ÀÛÀº ¿µ¾Æ
  • small intestine
    ÀÛÀºÃ¢ÀÚ, ¼ÒÀå
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • small cell carcinoma
    ¼Ò¼¼Æ÷¾ÏÁ¾
  • small intestine
    ÀÛÀºÃ¢ÀÚ, ¼ÒÀå
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reverse transcription
    ¿ªÀü»ç
  • transcription
    ˟ȍ
  • small cell carcinoma
    ¼Ò¼¼Æ÷¾ÏÁ¾
  • small cell lung cancer
    ÀÛÀº¼¼Æ÷ÇãÆÄ¾Ï, ¼Ò¼¼Æ÷Æó¾Ï
  • small intestine
    ÀÛÀºÃ¢ÀÚ, ¼ÒÀå
  • small pox
    µÎâ, õ¿¬µÎ
  • small angle strabismus
    ¹Ì¼¼°¢»ç½Ã
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • artery,small
    ¼Òµ¿¸Æ(á³ÔÑØæ)
  • Insulin-like growth factors
    Àν¶¸°¾ç(å×)¼ºÀå(à÷íþ)È£¸£¸ó
  • psychological factors affecting medical condition
    ÀÇÇÐÀû»óÅ¿¡ ¿µÇâÀ» ÁÖ´Â ½É¸®Àû ¿ä¼Ò.
  • psychological factors affecting physical condition
    ½Åü»óÅ¿¡ ¿µÇâÀ» ÁÖ´Â ½É¸®Àû ¿ä¼Ò.
  • quality factors
    Ư¼º ¿ä¼Ò, Áú ¿ä¼Ò
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • macrophage activating factor (MAF)
    ´ë½Ä¼¼Æ÷ Ȱ¼ºÀÎÀÚ
  • chimeric transcription tactor
  • leader RNA primed transcription
    ¼±µµ RNA ½Ã¹ßÀü»ç
  • reverse transcription
    ¿ªÀü»ç
  • reverse transcription
    ¿ªÀü»ç(æ½ï®ÞÐ).
  • transcription
    ˟ȍ
  • transcription factor
    Àü»çÀÎÀÚ
  • transcription factor II
  • coagulation factors
    ÀÀ°íÀÎÀÚ(¡­ì×í­)
  • exogenous factors
    ¿ÜÀμº ¿ä¼Ò(èâì×àõ é©áÈ).
  • exogenous factors
    ¿ÜÀμº ¿ä¼Ò(¡­é©áÈ).
  • factors
  • psychological factors affecting medical condition
    ÀÇÇÐÀû»óÅ¿¡ ¿µÇâÀ» ÁÖ´Â ½É¸®Àû ¿ä¼Ò.
  • psychological factors affecting physical condition
    ½Åü»óÅ¿¡ ¿µÇâÀ» ÁÖ´Â ½É¸®Àû ¿ä¼Ò.
  • quality factors
    Ư¼º ¿ä¼Ò, Áú ¿ä¼Ò
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Openings of small veins
    ¹Ì¼¼Á¤¸Æ±¸¸Û
    [¿¾ ¿ë¾î] ¼ÒÁ¤¸Æ±¸
  • Small saphenous vein
    ÀÛÀºµÎ··Á¤¸Æ
    [¿¾ ¿ë¾î] ¼Òº¹ÀçÁ¤¸Æ
  • Small lymphocyte
    ÀÛÀº¸²ÇÁ±¸
    [¿¾ ¿ë¾î] ¼ÒÀӯı¸
  • Small fusiform neuron
    ÀÛÀº¹æÃß¼¼Æ÷
    [¿¾ ¿ë¾î] ¼Ò¹æÃ߻󼼯÷
  • Small stellate neuron
    ÀÛÀºº°¼¼Æ÷
    [¿¾ ¿ë¾î] ¼Ò¼º»ó¼¼Æ÷
  • Small cell part
    ÀÛÀº¼¼Æ÷ºÎºÐ
    [¿¾ ¿ë¾î] ¼Ò¼¼Æ÷ºÎ
  • Small cardiac vein
    ÀÛÀº½ÉÀåÁ¤¸Æ
    [¿¾ ¿ë¾î] ¼Ò½ÉÀåÁ¤¸Æ
  • SMALL INTESTINE
    ÀÛÀºÃ¢ÀÚ [¼ÒÀå]
    [¿¾ ¿ë¾î] ¼ÒÀå
  • Small pyramidal neuron
    ÀÛÀºÇǶó¹Ô¼¼Æ÷
    [¿¾ ¿ë¾î] ¼ÒÃßü½Å°æ¼¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • MAF
    (å²) macrophage activating factor
  • fibroblast growth factors
    ¼¶À¯¾Æ¼¼Æ÷ ¼ºÀÚÀÎÀÚ (àéë«ä´á¬øàà÷íþì×í­)
  • suppressor factors
    ¾ï¾Ð(ÀÚ) ÀÎÀÚ(åääâ(í­)ì×í­)
  • small-angle x-ray diffraction
    ¼Ò°¢(á³ÊÇ) X-¼±(àÊ) ȸÀý(üÞï¹)
  • small calorie
    ¼Ò(á³) Ä®·Î¸®
  • small cytoplasmic ribonucleoproteins
    ¼Ò(á³) ¼¼Æ÷Áú(á¬øàòõ) ¶óÀ̺¸ÇÙ»ê´Ü¹éÁú(ú·ß«Ó±ÛÜòõ)
  • small cytoplasmic RNA
    ¼Ò(á³) ¼¼Æ÷Áú(á¬øàòõ)RNA
  • small lymphocyte
    ¼Ò(á³)Àӯı¸
  • small nuclear RNA
    ¼Ò(á³) ÇÙ(ú·)RNA
  • small nuclear ribonucleoprotein
    ¼Ò(á³) ÇÙ(ú·) ¶óÀ̺¸ÇÙ»ê´Ü¹éÁú(ú·ß«Ó±ÛÜòõ)
  • asymmetric transcription
    ºÒ±Õµî Àü»ç (ÝÕгÔõï®ÞÐ)
  • coupled transcription-translation
    µ¿½Ã Àü»ç¹ø¿ª(ÔÒãÁï®ÞÐÛèæ»)
  • divergent transcription
    ºÐÁö Àü»ç(ÝÂò«ï®ÞÐ)
  • reverse transcription
    ¿ªÀü»ç(æ½ï®ÞÐ)
  • rRNA transcription unit
    rRNA Àü»ç ´ÜÀ§(ï®ÞÐÓ¤êÈ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • quality factors
    Ư¼º¿ä¼Ò, Áú¿ä¼Ò
  • transcription
    º¹»ç, Àü»ç
  • small bowel series
    ¼ÒÀåÁ¶¿µ¼ú
  • small cell
    ¼Ò¼¼Æ÷
  • small cleaved cell
    ¼ÒºÐÇÒ¼¼Æ÷
  • small intestine
    ÀÛÀºÃ¢ÀÚ, ¼ÒÀå
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
MAF macrophage activation factor; macrophage agglutinating factor; maximum atrial fragmentation; minimum...
GnRH Gonadotropin Releasing Hormone  [HP 1898, 2034]
  = LHRH
  = Go...
SAS sarcoma amplified sequence; self-rating anxiety scale; short arm splint; Sklar Aphasia Scale; sleep ...
SCC self-care center; sequential combination chemotherapy; services for crippled children; short-course ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MAF Macrophage Activating Factor
MAF Macrophage activation factor
MARE Maf recognition element
MAF Mouse amniotic fluid
AEF Allogeneic effect factors
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • controlling factors in facial growth
    ¾È¸é ¼ºÀåÀÇ Á¶Àý ¿äÀÎ
  • MAF
    ´ë½Ä ¼¼Æ÷ Ȱ¼ºÈ­ ÀÎÀÚ
    macro
  • reverse transcription
    ¿ªÀü»ç
  • duplication of small intestine
    ¼ÒÀåÀÇ Áߺ¹Áõ
  • mixed small and large cell lymphoma
    È¥ÇÕ¼º ´ë¼Ò¼¼Æ÷ ¸²ÇÁÁ¾
  • openings of small vein
    ¹Ì¼¼ Á¤¸Æ ±¸¸Û
  • small atrial septal defect
    ¹Ì¼¼ ½É¹æ Áß°Ý °á¼Õ
  • small bowel series
    ¼ÒÀå Á¶¿µ¼ú
  • small cell
    ¼Ò¼¼Æ÷
  • small cleaved cell
    ¼ÒºÐÇÒ ¼¼Æ÷
  • small intestine
    ÀÛÀº âÀÚ, ¼ÒÀå
    µ¿ÀǾî=intestinum tenue. 1. À§¿Í ´ëÀå »çÀÌ¿¡ ÀÖ´Â ±æÀÌ 6¡­7 m¿¡ À̸£´Â ¼ÒÈ­°ü. À§¾×¿¡ ÀÇÇØ ¾ÏÁ×ó·³ µÈ À½½Ä¹°Àº ¼ÒÀåÀ» Åë°úÇÏ´Â »çÀÌ¿¡ ¼ÒÀ庮¿¡¼­ ºÐºñµÇ´Â Àå¾×, °£¿¡¼­ ¸¸µé¾îÁö´Â ¾µ°³Áó, ÀÌÀÚ¿¡¼­ ³ª¿À´Â ÀÌÀÚ¾× µî°ú È¥ÇյȴÙ. ¼ÒÀåÀº ¼ÒÈ­ ¿îµ¿À» Çϸ鼭 ¿µ¾çºÐÀ» ¼ÒÈ­, Èí¼öÇÏ´Â Áß¿äÇÑ ºÎºÐÀÌ´Ù. ¼ÒÀåÀº À§¿¡¼­ºÎÅÍ ½ÊÀÌÁöÀå, °øÀå, ȸÀåÀÇ ¼¼ ºÎºÐÀ¸·Î ±¸ºÐÇÑ´Ù. °øÀå°ú ȸÀåÀÇ ±æÀÌÀÇ ºñ´Â ¾à 2:3 Á¤µµÀ̸ç, ½ÊÀÌÁöÀåÀº Èĺ¹º®¿¡ ưưÇÏ°Ô °íÁ¤µÇ¾î ÀÖÀ¸³ª, °øÀå°ú ȸÀåÀº º¹°­ ¼Ó¿¡ ±æ°Ô ÆÛÁ®¼­ Àå°£¸·¿¡ ÀÇÇÏ¿© º¹º®¿¡ ¿¬°áµÇ¾î ÀÖ´Ù. ±×·±µ¥´Ù Àå°£¸·ÀÇ ±æÀ̰¡ 15¡­25 cm³ª µÇ¹Ç·Î, °øÀå°ú ȸÀåÀº °¡µ¿¼ºÀÌ Å©´Ù. °øÀå°ú ȸÀåÀ» ÇÕÃļ­ À¯Àå°£¸· ¼ÒÀåÀ̶ó°í ÇÑ´Ù. °øÀåÀº ȸÀ庸´Ù ¾à°£ ±½°í º®ÀÌ µÎ²¨¿ì¸ç, Ç÷°üÀÇ ºÐÆ÷µµ °øÀå¿¡ ¸¹´Ù. ½Ãü¸¦ ÇØºÎÇßÀ» °æ¿ì, °øÀåÀº ³»¿ë¹°ÀÌ ºñ¾î ÀÖ´Â °æ¿ì°¡ ¸¹°í, ȸÀåÀº º¹°­ ¼Ó¿¡¼­ ²ÙºÒ²ÙºÒÇÏ°Ô µÇ¾î Àֱ⠶§¹®¿¡ ÀÌ¿Í °°ÀÌ ¸í¸íµÇ¾ú´Ù. ¼ÒÀå ³»¸éÀÇ Á¡¸·¿¡´Â À±»óÀ¸·Î »¸¾îÀÖ´Â ¼ö¸¹Àº ÁÖ¸§ÀÌ ÀÖ°í, ÁÖ¸§ÀÇ Ç¥¸é¿¡´Â À¶¸ð¶ó°í ÇÏ´Â ±æÀÌ 0.5¡­1 mmµÇ´Â Á¡¸· µ¹±â°¡ »ª»ªÇÏ°Ô µ¸¾Æ ÀÖ´Ù. À¶¸ð »çÀÌ·Î Á¡¸· Á¶Á÷¿¡ µé¾î ÀÖ´Â Àå¼±ÀÌ ¿­·Á ÀÖ¾î Àå¾×À» ÀÌ °÷À¸·Î ºÐºñÇÑ´Ù. À±»óÀÇ ÁÖ¸§Àº ½ÊÀÌÁöÀå°ú °øÀå¿¡´Â ¸¹À¸³ª ȸÀå¿¡´Â Àû´Ù. ¼ÒÀå Á¡¸·¿¡´Â Ư¼öÇÑ ¸²ÇÁ Á¶Á÷ÀÌ ¹ß´ÞÇØ Àִµ¥ À̰Ϳ¡´Â µÎ Á¾·ù°¡ ÀÖ´Ù. Çϳª´Â Á¡¸·¸é¿¡ Áö¸§ 1¡­1.5 mmÀ̰í Èò»öÀ» ¶í µ¹Ã⹰ó·³ º¸ÀÌ´Â °í¸³ ¸²ÇÁ ¼ÒÀý·Î¼­, ÀÌ ¸²ÇÁ ¼ÒÀýÀº Àå Àüü¿¡ ÆÛÁ® ÀÖ´Ù. ´Ù¸¥ Çϳª´Â ÁýÇÕ ¸²ÇÁ ¼ÒÀý·Î À̰ÍÀº °í¸³ ¸²ÇÁ ¼ÒÀýÀÌ ¹ÐÁýÇÑ °ÍÀ¸·Î, Áö¸§ 2¡­10 cmÀÎ ±äÀå Ÿ¿øÇüÀ» ÀÌ·ç°í ÀÖÀ¸¸ç ¼ÒÀýÀÇ ÀåÃàÀº ÀåÀÇ ±äÃà ¹æÇâ°ú ÀÏÄ¡Çϰí Àִµ¥, ±× ¼ö´Â ¾à 15¡­30°³ Á¤µµÀÌ´Ù. Àå °áÇÙÀ̳ª ÀåÆ¼Çª½º µî¿¡ °É¸®¸é ÀÌ ºÎºÐ¿¡¼­ ±Ë¾çÀÌ »ý±ä´Ù. ¼ÒÀåÀÇ ±â´É¿¡´Â ¿îµ¿ ±â´É, ºÐºñ ±â´É, Èí¼ö ±â´ÉÀÇ ¼¼ °¡Áö°¡ ÀÖ´Ù. 2. À¯¹® ¾Æ·¡¿¡¼­ ¸ÍÀå Àü¿¡ À̸£´Â 5-6m ±æÀÌÀÇ ¼ÒÈ­°üÀ¸·Î ½ÊÀÌÁöÀå, °øÀå, ȸÀåÀÇ 3ºÎºÐÀ¸·Î ±¸¼ºµÇ¾î ÀÖ°í, ¼ÒÈ­µÈ ¿µ¾çºÐÀ» Èí¼ö Ç÷·ù³ª ¸²ÇÁ°üÀ¸·Î ¿î¹ÝÇÏ´Â ¿ªÇÒÀ» ÇÑ´Ù.
  • small lymphocyte
    ÀÛÀº ¸²ÇÁ±¸, ¼Ò¸²ÇÁ±¸
  • small patent ductus arteriosus
    ¹Ì¼¼ µ¿¸Æ°ü °³Á¸
  • small pox
    µÎâ, õ¿¬µÎ
    1. µÎâ ¹ÙÀÌ·¯½º¿¡ ÀÇÇϳª, ÀÌ ¹ÙÀÌ·¯½º´Â ȯÀÚÀÇ ºñÀεΠºÐºñ¾×, ³óÆ÷, Ç÷¾× Áß¿¡ ÀÖÀ¸¸ç, °ÇÁ¶¿¡ °­ÇÏ°í ¸ÕÁö ¼Ó¿¡¼­µµ ¸î °³¿ù¾¿ »ýÁ¸ÇÏ°í °¨¿°·ÂÀÌ °­ÇÏ´Ù. ±â¹°, °ø±â¸¦ ÅëÇÏ¿©¼­µµ Àü¿°ÇÑ´Ù. µ¿³²¾Æ½Ã¾Æ¿¡ µÎâ »óÀçÁö°¡ ÀÖ´Ù. Àẹ±â´Â 11-14ÀÏ, Á¾µÎ¸¦ ¹ÞÀº ºÒ¿ÏÀü ¸é¿ª »óÅ¿¡¼­´Â 3ÁÖ°£ Á¤µµ ¿¬ÀåÇÑ´Ù. ¸é¿ªÀÌ ÀüÇô ¾ø´Â °æ¿ì¿¡ ÁøµÎÀÇ Áõ»óÀ» ³ªÅ¸³»°í ºÒ¿ÏÀüÇÑ ¸é¿ª »óÅÂÀÇ °æ¿ì¿¡´Â °æÁõÀÇ °¡µÎÀÇ Áõ»óÀ» ³ªÅ¸³½´Ù. ÇÕº´ÁõÀº ¼¼±Õ¿¡ ÀÇÇÑ 2Â÷ °¨¿°ÀÌ ¸¹´Ù. Ä¡·á´Â ´ëÁõÀûÀ¸·Î ¿¹¹æÀº Á¾µÎ ȯÀÚÀÇ Á¶±â ¿ÏÀü °Ý¸®ÀÌ´Ù. 2. Æø½º ¹ÙÀÌ·¯½º°ú
  • small pox vaccination
    õ¿¬µÎ ¿¹¹æ Á¢Á¾
    Jenner¿¡ ÀÇÇØ °³¹ßµÈ õ¿¬µÎ ¹é½ÅÀÇ µµ¿òÀ¸·Î 1977³â 10¿ù ¼Ò¸»¸®¾Æ¿¡¼­ÀÇ È¯ÀÚ ¹ß»ý°ú 1978³â ½ÇÇè½Ç¿¡¼­ ¹ß»ýÇÑ µÎ°ÇÀ» ³¡À¸·Î Áö±¸»ó¿¡¼­ õ¿¬µÎ´Â ¿ÏÀüÈ÷ »ç¶óÁö°Ô µÇ¾ú´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
transcription factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.
(12 Dec 1998)
transcription factors, tfii The so-called general transcription factors that bind to RNA polymerase II and that are required to initiate transcription. They include tfiia, tfiib, tfiid, tfiie, tfiif, tfiih, tfii-I, and tfiij. In vivo they apparently bind in an ordered multi-step process and/or may form a large preinitiation complex called RNA polymerase II holoenzyme.
(12 Dec 1998)
transcription factors, tfiii Factors that bind to RNA polymerase III and aid in transcription. They include the assembly factors tfiiia and tfiiic and the initiation factor tfiiib. All combine to form a preinitiation complex at the promotor that directs the binding of RNA polymerase III.
(12 Dec 1998)
MAF <abbreviation> Macrophage-activating factor.
(05 Mar 2000)
reverse transcription <molecular biology> The process of copying information found in RNA into DNA.
(09 Oct 1997)
transcription <molecular biology> Synthesis of RNA by RNA polymerases using a DNA template.
(18 Nov 1997)
transcription factor <molecular biology> Protein required for recognition by RNA polymerases of specific stimulatory sequences in eukaryotic genes.
Several are known that activate transcription by RNA polymerase II when bound to upstream promoters.
Transcription of the 5S RNA gene in Xenopus by RNA polymerase III is dependent on a 40 kD protein TFIIIA that binds to a regulatory site in the centre of the gene and was the first protein found to exhibit the metal binding domains known as zinc fingers.
(17 Mar 1998)
transcription factor ap-1 A multiprotein complex composed of the products of c-jun and c-fos proto-oncogenes. These proteins must dimerise in order to bind to the ap-1 recognition site, also known as the tpa-responsive element (tre). Ap-1 controls both basal and inducible transcription of several genes.
(12 Dec 1998)
transcription factor, sp1 Promoter-specific RNA polymerase II transcription factor that binds to the gc box, one of the upstream promoter elements (upe) in mammalian cells. The binding of sp1 is necessary to initiate transcription in the promoters of a variety of cellular and viral genes including c-ha-ras and HIV.
(12 Dec 1998)
transcription, genetic The transfer of genetic information from DNA to messenger RNA by DNA-directed RNA polymerase. It includes reverse transcription and transcription of early and late genes expressed early in an organism's life cycle or during later development.
(12 Dec 1998)
transcription unit <molecular biology> A region of DNA that is transcribed to produce a single primary RNA transcript, i.e. A newly synthesised RNA molecule that has not been processed.
Transcription units can be mapped by kinetic studies of RNA synthesis and in some instances directly visualised by electron microscopy.
(17 Mar 1998)
erythroid transcription factor <molecular biology> Transcription factor that binds to regulatory regions of genes expressed in erythroid cells.
(18 Nov 1997)
age factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from aging, a physiological process, and time factors which refers only to the passage of time.
(12 Dec 1998)
bacteriocin factors Bacterial plasmid's responsible for the elaboration of bacteriocins.
Synonym: bacteriocin factors, bacteriocinogens.
(05 Mar 2000)
B-cell differentiation/growth factors Various substances, usually obtained from the supernatant of T-cell cultures, such as interleukin 4, 5, and 6. These substances are necessary for B-cell growth, maturation, and differentiation into plasma cells or B memory cells.
(05 Mar 2000)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Maf Transcription Factors, Small - »õâ A family of Maf Transcription Factors that lack activation domains. Small Maf proteins function as transcriptional repressors or form heterodimeric complexes to serve as transcriptional coactivators. Small Maf proteins include MafF, MafG, and MafK.
    Synonyms : Small Maf Transcription Factors
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transcription
    ˟ȍ
  • electrical transcription
    ³ìÀ½ ¹æ¼Û¿ä(·¹ÄÚµå,Å×ÀÌÇÁ);³ìÀ½
  • transcription
    ÇÊ»ç;¸ð»ç;º¹»ç;¹Ù²ã ¾¸;Àü»ç;¹Ù²ã¾´ °Í
  • small
    ÀÛÀº,ÀÛÀººÎºÐ,ÀÛÀº ¼Ò¸®·Î
  • small
    ÀÛÀº;Á¼Àº;(¼öÀÔ µûÀ§)ÀûÀº;½Ã½ÃÇÑ;ÇÏÂúÀº;ÀλöÇÑ (a man of ~ mind ¼ÒÀÎ);and ~ wonder;...À̶ó°í ÇØ¼­ ³î¶ö °ÍÀº ¸ø µÈ´Ù;feel ~ ¶¸¶¸Ä¡¸øÇϰÔ(ºÎ²ô·´°Ô)¿©±â´Ù;look~ Ç®ÀÌ Á×´Ù;ÀÛ°Ô;ÀÛÀº (¸ñ)¼Ò¸®
  • small arms
    ÈÞ´ë¿ë ¹«±â
  • small beer
    ¾àÇÑ ¸ÆÁÖ;ÇÏÂúÀº °Í
  • small capital
    ¼ÒÇü ´ë¹®ÀÚ
  • small change
    Àܵ·;½Ã½ÃÇÑ À̾߱â
  • small fry
    ¾î¸°¾Öµé;ÀÛÀº µ¿¹°;½Ã½ÃÇÑ Ä£±¸µé;ÀÛÀº µ¿¹°;µ¿¹°ÀÇ »õ³¢;ÀÛÀº ¹°°í±â
  • small holder
    ¼Ò ÀÚÀÛ³ó
  • small holding
    ¼ÒÀÚÀÛ ³óÁö
  • small hours
    ÇѹãÁß(1,2,3½Ã°æ)
  • small potatoes
    ½Ã½ÃÇÑ °Í
  • small rain
    ºÎ½½ºñ;À̽½ºñ !
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á